Collaborative multicenter investigation of marrow transplantation for sickle cell disease: Current results and future directions

Mark C. Walters, Melinda Patience, Wendy Leisenring, Zora R. Rogers, Patricia Dinndorf, Sally C. Davies, Irene A G Roberts, Andrew M Yeager, Joanne Kurtzberg, Nancy Bunin, J. Paul Scott, Donna A. Wall, Alan S. Wayne, Joseph Wiley, Patrick J. Darbyshire, William C. Mentzer, Franklin O. Smith, Keith M. Sullivan

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

We present updated results of a multicenter collaborative investigation of bone marrow transplantation for sickle cell disease. Between September 1991 and April 1997, thirty-four children less than 16 years of age with severe sickle cell disease received marrow allografts from HLA-identical siblings. Indications for transplantation included a history of stroke (n=17), recurrent acute chest syndrome or sickle pulmonary disease (n=10), and recurrent vaso-occlusive crises (n=7). Twenty-one patients received regular red blood cell (RBC) transfusions to prevent complications of sickle cell disease. Patients were prepared for transplantation with busulfan, cyclophosphamide, and antithymocyte globulin or CAMPATH (Cambridge Pathology) antibody. Thirty-two of the 34 patients survived, with a median follow-up of 26.5 months (range, 0.2-66.9 months); and 28 patients demonstrated stable engraftment of donor hematopoietic cells. Graft rejection or recurrence of sickle cell disease occurred in four patients, and two patients died of intracranial hemorrhage or graft-vs.-host disease. In the group of 34 children with symptoms of advanced sickle cell disease, current Kaplan-Meier estimates of survival and event-free survival are 93% and 79%, respectively.

Original languageEnglish (US)
Pages (from-to)310-315
Number of pages6
JournalBiology of Blood and Marrow Transplantation
Volume3
Issue number6
StatePublished - Dec 1997
Externally publishedYes

Fingerprint

Sickle Cell Anemia
Transplantation
Bone Marrow
Acute Chest Syndrome
Busulfan
Erythrocyte Transfusion
Antilymphocyte Serum
Intracranial Hemorrhages
Kaplan-Meier Estimate
Graft Rejection
Bone Marrow Transplantation
Cyclophosphamide
Lung Diseases
Disease-Free Survival
Allografts
Direction compound
Siblings
Stroke
Tissue Donors
Pathology

Keywords

  • Bone marrow transplantation
  • Sickle cell disease

ASJC Scopus subject areas

  • Transplantation

Cite this

Walters, M. C., Patience, M., Leisenring, W., Rogers, Z. R., Dinndorf, P., Davies, S. C., ... Sullivan, K. M. (1997). Collaborative multicenter investigation of marrow transplantation for sickle cell disease: Current results and future directions. Biology of Blood and Marrow Transplantation, 3(6), 310-315.

Collaborative multicenter investigation of marrow transplantation for sickle cell disease : Current results and future directions. / Walters, Mark C.; Patience, Melinda; Leisenring, Wendy; Rogers, Zora R.; Dinndorf, Patricia; Davies, Sally C.; Roberts, Irene A G; Yeager, Andrew M; Kurtzberg, Joanne; Bunin, Nancy; Scott, J. Paul; Wall, Donna A.; Wayne, Alan S.; Wiley, Joseph; Darbyshire, Patrick J.; Mentzer, William C.; Smith, Franklin O.; Sullivan, Keith M.

In: Biology of Blood and Marrow Transplantation, Vol. 3, No. 6, 12.1997, p. 310-315.

Research output: Contribution to journalArticle

Walters, MC, Patience, M, Leisenring, W, Rogers, ZR, Dinndorf, P, Davies, SC, Roberts, IAG, Yeager, AM, Kurtzberg, J, Bunin, N, Scott, JP, Wall, DA, Wayne, AS, Wiley, J, Darbyshire, PJ, Mentzer, WC, Smith, FO & Sullivan, KM 1997, 'Collaborative multicenter investigation of marrow transplantation for sickle cell disease: Current results and future directions', Biology of Blood and Marrow Transplantation, vol. 3, no. 6, pp. 310-315.
Walters, Mark C. ; Patience, Melinda ; Leisenring, Wendy ; Rogers, Zora R. ; Dinndorf, Patricia ; Davies, Sally C. ; Roberts, Irene A G ; Yeager, Andrew M ; Kurtzberg, Joanne ; Bunin, Nancy ; Scott, J. Paul ; Wall, Donna A. ; Wayne, Alan S. ; Wiley, Joseph ; Darbyshire, Patrick J. ; Mentzer, William C. ; Smith, Franklin O. ; Sullivan, Keith M. / Collaborative multicenter investigation of marrow transplantation for sickle cell disease : Current results and future directions. In: Biology of Blood and Marrow Transplantation. 1997 ; Vol. 3, No. 6. pp. 310-315.
@article{b69c6baeffd74d32b7311423b99a2061,
title = "Collaborative multicenter investigation of marrow transplantation for sickle cell disease: Current results and future directions",
abstract = "We present updated results of a multicenter collaborative investigation of bone marrow transplantation for sickle cell disease. Between September 1991 and April 1997, thirty-four children less than 16 years of age with severe sickle cell disease received marrow allografts from HLA-identical siblings. Indications for transplantation included a history of stroke (n=17), recurrent acute chest syndrome or sickle pulmonary disease (n=10), and recurrent vaso-occlusive crises (n=7). Twenty-one patients received regular red blood cell (RBC) transfusions to prevent complications of sickle cell disease. Patients were prepared for transplantation with busulfan, cyclophosphamide, and antithymocyte globulin or CAMPATH (Cambridge Pathology) antibody. Thirty-two of the 34 patients survived, with a median follow-up of 26.5 months (range, 0.2-66.9 months); and 28 patients demonstrated stable engraftment of donor hematopoietic cells. Graft rejection or recurrence of sickle cell disease occurred in four patients, and two patients died of intracranial hemorrhage or graft-vs.-host disease. In the group of 34 children with symptoms of advanced sickle cell disease, current Kaplan-Meier estimates of survival and event-free survival are 93{\%} and 79{\%}, respectively.",
keywords = "Bone marrow transplantation, Sickle cell disease",
author = "Walters, {Mark C.} and Melinda Patience and Wendy Leisenring and Rogers, {Zora R.} and Patricia Dinndorf and Davies, {Sally C.} and Roberts, {Irene A G} and Yeager, {Andrew M} and Joanne Kurtzberg and Nancy Bunin and Scott, {J. Paul} and Wall, {Donna A.} and Wayne, {Alan S.} and Joseph Wiley and Darbyshire, {Patrick J.} and Mentzer, {William C.} and Smith, {Franklin O.} and Sullivan, {Keith M.}",
year = "1997",
month = "12",
language = "English (US)",
volume = "3",
pages = "310--315",
journal = "Biology of Blood and Marrow Transplantation",
issn = "1083-8791",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Collaborative multicenter investigation of marrow transplantation for sickle cell disease

T2 - Current results and future directions

AU - Walters, Mark C.

AU - Patience, Melinda

AU - Leisenring, Wendy

AU - Rogers, Zora R.

AU - Dinndorf, Patricia

AU - Davies, Sally C.

AU - Roberts, Irene A G

AU - Yeager, Andrew M

AU - Kurtzberg, Joanne

AU - Bunin, Nancy

AU - Scott, J. Paul

AU - Wall, Donna A.

AU - Wayne, Alan S.

AU - Wiley, Joseph

AU - Darbyshire, Patrick J.

AU - Mentzer, William C.

AU - Smith, Franklin O.

AU - Sullivan, Keith M.

PY - 1997/12

Y1 - 1997/12

N2 - We present updated results of a multicenter collaborative investigation of bone marrow transplantation for sickle cell disease. Between September 1991 and April 1997, thirty-four children less than 16 years of age with severe sickle cell disease received marrow allografts from HLA-identical siblings. Indications for transplantation included a history of stroke (n=17), recurrent acute chest syndrome or sickle pulmonary disease (n=10), and recurrent vaso-occlusive crises (n=7). Twenty-one patients received regular red blood cell (RBC) transfusions to prevent complications of sickle cell disease. Patients were prepared for transplantation with busulfan, cyclophosphamide, and antithymocyte globulin or CAMPATH (Cambridge Pathology) antibody. Thirty-two of the 34 patients survived, with a median follow-up of 26.5 months (range, 0.2-66.9 months); and 28 patients demonstrated stable engraftment of donor hematopoietic cells. Graft rejection or recurrence of sickle cell disease occurred in four patients, and two patients died of intracranial hemorrhage or graft-vs.-host disease. In the group of 34 children with symptoms of advanced sickle cell disease, current Kaplan-Meier estimates of survival and event-free survival are 93% and 79%, respectively.

AB - We present updated results of a multicenter collaborative investigation of bone marrow transplantation for sickle cell disease. Between September 1991 and April 1997, thirty-four children less than 16 years of age with severe sickle cell disease received marrow allografts from HLA-identical siblings. Indications for transplantation included a history of stroke (n=17), recurrent acute chest syndrome or sickle pulmonary disease (n=10), and recurrent vaso-occlusive crises (n=7). Twenty-one patients received regular red blood cell (RBC) transfusions to prevent complications of sickle cell disease. Patients were prepared for transplantation with busulfan, cyclophosphamide, and antithymocyte globulin or CAMPATH (Cambridge Pathology) antibody. Thirty-two of the 34 patients survived, with a median follow-up of 26.5 months (range, 0.2-66.9 months); and 28 patients demonstrated stable engraftment of donor hematopoietic cells. Graft rejection or recurrence of sickle cell disease occurred in four patients, and two patients died of intracranial hemorrhage or graft-vs.-host disease. In the group of 34 children with symptoms of advanced sickle cell disease, current Kaplan-Meier estimates of survival and event-free survival are 93% and 79%, respectively.

KW - Bone marrow transplantation

KW - Sickle cell disease

UR - http://www.scopus.com/inward/record.url?scp=0031299076&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031299076&partnerID=8YFLogxK

M3 - Article

C2 - 9502298

AN - SCOPUS:0031299076

VL - 3

SP - 310

EP - 315

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

SN - 1083-8791

IS - 6

ER -